Smart Spectrophotometric Methods for Concurrent Determination of Furosemide and Spironolactone Mixture in Their Pharmaceutical Dosage Forms

Authors

  • Hayam mahmoud Lotfy Pharmaceutical Chemistry Department, Faculty of Pharmacy, Future University in Egypt, Egypt
  • Sara Mohamed Elhanboushy Pharmaceutical Chemistry Department, Faculty of Pharmacy, Future University in Egypt, Egypt https://orcid.org/0000-0002-8446-3963
  • Yasmine Fayez Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Egypt
  • Mohamed Abdelkawy Pharmaceutical Chemistry Department, Faculty of Pharmacy, Future University in Egypt, Egypt

DOI:

https://doi.org/10.1590/s2175-97902022e19487

Keywords:

Absorbance subtraction method (AS), Amplitude modulation method (AM), Ratio subtraction method (RS), Constant multiplication method (CM), Ratio difference method (RD)

Abstract

Simple, precise, accurate and specific spectrophotometric methods are progressed and validated for concurrent analysis of Furosemide (FUR) and Spironolactone (SPR) in their combined dosage form depend on spectral analysis procedures. Furosemide (FUR) in the binary mixture could be analyzed at its λmax 274 nm using its recovered zero order absorption spectrum using constant multiplication method (CM). Spironolactone (SPR) in the mixture could be analyzed at its λmax 238 nm by ratio subtraction method (RS). Concurrent determination for FUR and SPR in their mixture could be applied by amplitude modulation method (AM), absorbance subtraction method (AS) and ratio difference (RD). Linearity ranges of FUR and SPR were (2.0µg/mL-22.0 µg/mL) and (3.0µg/mL-30.0 µg/mL), respectively. Specificity of the proposed spectrophotometric methods was examined by analyzing the prepared mixtures in laboratory and was applied successfully for pharmaceutical dosage form analysis which have the cited drugs without additives contribution. The proposed spectrophotometric methods were also validated as per as the guidelines of ICH. Statistical comparison was performed between the obtained results with those from the official methods of the cited drugs, using one-way ANOVA, F-test and student t-test. The results are exhibiting insignificant difference concerning precision and accuracy.

Downloads

Download data is not yet available.

References

Al‐Ghamdi AH, Al‐Ghamdi AF, Al‐Omar MA. Electrochemical studies and square‐wave adsorptive stripping voltammetry of spironolactone drug. Anal Lett. 2008;41(1):90-103.

Baranowska I, Markowski P, Baranowski J. Development and validation of an HPLC method for the simultaneous analysis of 23 selected drugs belonging to different therapeutic groups in human urine samples. Anal Sci. 2009;25(11):1307-1313.

Bosch ME, Sánchez AR, Rojas FS, Ojeda CB. Analytical determination of furosemide: the last researches. Int J Pharm Biol Sci. 2013;3(4):168-181.

Chavan RR, Bhinge SD, Bhutkar MA, Randive DS. Development and validation of spectrophotometric methods for simultaneous estimation of furosemide and spironolactone by Vierordt’s method in bulk and combined tablet dosage form. Acta Chem Iasi. 2018;26(1):74-90.

Dinç E, Üstündağ Ö. Spectophotometric quantitative resolution of hydrochlorothiazide and spironolactone in tablets by chemometric analysis methods. Il Farmaco. 2003;58(11):1151-1161.

El-Shahawi MS, Bashammakh AS, Al-Sibaai AA, Bahaidarah EA. Analysis of spironolactone residues in industrial wastewater and in drug formulations by cathodic stripping voltammetry. J Pharm Anal. 2013;3(2):137-143.

Emam AA, Abdelaleem EA, Naguib IA, Abdallah FF, Ali NW. Successive ratio subtraction as a novel manipulation of ratio spectra for quantitative determination of a mixture of furosemide, spironolactone and canrenone. Spectrochim Acta Part A. 2018;192:427-436.

Golher HK, Kapse K, Singh SK. Simultaneous spectrophotometric estimation of torsemide and spironolactone in tablet dosage form. Int J Pharmtech Res. 2011;2(4):2246-2250.

Hegazy MA, Metwaly FH, Abdelkawy M, Abdelwahab NS. Spectrophotometric and chemometric determination of hydrochlorothiazide and spironolactone in binary mixture in the presence of their impurities and degradants. Drug Test Anal. 2010;2(5):243-251.

ICH. International Conference on Harmonization (ICH), Q2B: Validation of Analytical Procedures: Methodology, 62, US FDA Federal Register. 1997.

Israt S, Uddin M, Jahan R, Karim M. Simultaneous determination of furosemide and spironolactone in pharmaceutical formulations by spectrophotometric method using principal component regression. Bangladesh J Sci Ind Res. 2016;51(4):297-306.

Kher G, Ram V, Kher M, Joshi H. Development and validation of HPTLC method for simultaneous determination of furosemide and spironolactone in its tablet formulation. Res J Pharm Biol Chem Sci. 2013;4(1):365-377.

Kor K, Zarei K. Development and characterization of an electrochemical sensor for furosemide detection based on electropolymerized molecularly imprinted polymer. Talanta. 2016;146:181-187.

Kundu P, Pani NR, Barik A, Mishra B. An analysis of carvedilol and spironolactone in pharmaceutical dosage form and dissolution samples by simultaneous equation method and derivative method. Biopharm J. 2017;2(3):77-86.

Lee J-H, An T-G, Kim SJ, Shim W-S, Lee K-T. Development of liquid chromatography tandem mass spectrometry method for determination of spironolactone in human plasma: application to a bioequivalence study of Daewon Spiracton tablet® (spironolactone 50 mg). J Pharm Invest. 2015;45(6):601-609.

Lotfy HM, Hagazy MA-M. Comparative study of novel spectrophotometric methods manipulating ratio spectra: an application on pharmaceutical ternary mixture of omeprazole, tinidazole and clarithromycin. Spectrochim Acta Part A. 2012;96:259-270.

Lotfy HM, Hegazy MA, Rezk MR, Omran YR. Novel spectrophotometric methods for simultaneous determination of timolol and dorzolamide in their binary mixture. Spectrochim Acta Part A. 2014;126:197-207.

Lotfy HM, Hegazy MAM. Simultaneous determination of some cholesterol-lowering drugs in their binary mixture by novel spectrophotometric methods. Spectrochim Acta Part A. 2013;113:107-114.

Ma Y, Peng Y, Xu Y, Yang G, Hu Q. Determination of atenolol, rosuvastatin, spironolactone, glibenclamide and naproxen in blood by rapid analysis liquid chromatography. Asian J Chem. 2010;22(2):1136-1140.

Malode SJ, Abbar JC, Shetti NP, Nandibewoor ST. Voltammetric oxidation and determination of loop diuretic furosemide at a multi-walled carbon nanotubes paste electrode. Electrochim Acta. 2012;60:95-101.

Maulik B, Ketan D, Shital F. Development and validation of RP-HPLC method for simultaneous estimation of furosemide and spironolactone in their combined tablet dosage form. J Pharm Sci Biosci Res. 2012;2(3):144-147.

Medeiros RA, Baccarin M, Fatibello-Filho O, Rocha-Filho RC, Deslouis C, Debiemme-Chouvy C. Comparative study of basal-plane pyrolytic graphite, boron-doped diamond, and amorphous carbon nitride electrodes for the voltammetric determination of furosemide in pharmaceutical and urine samples. Electrochim Acta. 2016;197:179-185.

Millership J, Parker C, Donnelly D. Ratio spectra derivative spectrophotometry for the determination of furosemide and spironolactone in a capsule formulation. Il Farmaco. 2005;60(4):333-338.

Naguib IA, Abdelaleem EA, Emam AA, Ali NW, Abdallah FF. Development and validation of HPTLC and green HPLC methods for determination of furosemide, spironolactone and canrenone, in pure forms, tablets and spiked human plasma. Biomed Chromatogr. 2018;32(10):e4304.

Patel H, Solanki S. Development and validation of spectrophotometric methods for simultaneous estimation of furosemide and spironolactone in combined tablet dosage form. Int J Pharm Pharm Sci. 2012;4(4):383-386.

Patel H, Solanki S. Simultaneous Estemation of Furosemide and Spironolactone in Combined Pharmaceutical Dosage Form by RP-HPLC. Asian J Pharm Clin Res. 2012;5(3):195-198.

Pharmacopoeia B. The Stationery Office on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA), London, United Kingdom. 2007;6.

Pharmacopoeia E. European pharmacopoeia. Strasbourg: Council of Europe. 2002.

Rajalakshmi S, Kumar LK, Priyanka VK, Manohar Y. A simultaneous estimation of torsemide and spironolactone and forced degradation studies in bulk and combined dosage form by RP-HPLC. Int J Pharm Bio Sci. 2018;9(1):143-150.

Ram RR, Ram VR, Joshi HS. Analytical Method Validation of Simultaneous determination of Spironolactone and Furosemide in tablet formulation and its Statistical evaluation. Int Lett Chem, Phys Astron. 2015;42:25-35.

Ram VR, Dave PN, Joshi HS. Development and validation of a stability-indicating HPLC assay method for simultaneous determination of spironolactone and furosemide in tablet formulation. J Chromatogr Sci. 2012;50(8):721-726.

Reynolds JE. Martindale: the extra pharmacopoeia, London, UK; The Pharmaceutical Press. 1982.

Saleh SS, Lotfy HM, Hassan NY, Elgizawy SM. A comparative study of validated spectrophotometric and TLC- spectrodensitometric methods for the determination of sodium cromoglicate and fluorometholone in ophthalmic solution. Saudi Pharm J. 2013;21(4):411-421.

Saleh SS, Lotfy HM, Hassan NY, Salem H. A comparative study of progressive versus successive resolution techniques applied for pharmaceutical ternary mixtures. Spectrochim Acta Part A. 2014;132:239-248.

Santini AO, Pezza HR, Sequinel R, Rufino JL, Pezza L. Potentiometric sensor for furosemide determination in pharmaceuticals, urine, blood serum and bovine milk. J Braz Chem Soc. 2009;20(1):64-73.

Sawant Ramesh L, Bharat Anjali V, Tanpure Kallyani D, Jadhav Kallyani A. Spectroscopic methods for the simultaneous estimation of theophylline and furosemide. Pharm Lett. 2015;7(2):199-205.

Semaan FS, Pinto EM, Cavalheiro ET, Brett C. A graphite‐polyurethane composite electrode for the analysis of furosemide. Electroanalysis. 2008;20(21):2287-2293.

Sharma M, Sharma S, Kohli D, Sharma A. Validated TLC densitometric method for the quantification of torsemide and spironolactone in bulk drug and in tablet dosage form. Scholars Res Libr. 2010;2(1):121-126.

Smajdor J, Piech R, Paczosa-Bator B. Spironolactone voltammetric determination on renewable amalgam film electrode. Steroids. 2018;130:1-6.

Tekerek E, Şukuroglu M, Okan A. Quantitative determination of hydrochlorothiazide and spironolactone in tablets by spectrophotometric and HPLC methods. Turk J Pharm Sci. 2008;5(2):53-66.

Vaidya V, Khanolkar M, Gadre J. Isocratic, simultaneous HPLC determination of frusemide and spironolactone in pharmaceutical dosage form by ion-pair chromatography. Indian Drugs. 2002;39(7):373-377.

Vlase L, Imre S, Muntean D, Achim M, Muntean D-L. Determination of spironolactone and canrenone in human plasma by high-performance liquid chromatography with mass spectrometry detection. Croat Chem Acta. 2011;84(3):361-366.

Walash M, El-Enany N, Eid M, Fathy M. Micellar high performance liquid chromatographic determination of furosemide and spironolactone in combined dosage forms. Application to human plasma. J Pharm Res. 2012;5(5):2648-2656.

Walash M, El-Enany N, Eid M, Fathy M. Simultaneous determination of metolazone and spironolactone in raw materials, combined tablets and human urine by high performance liquid chromatography. Anal Methods. 2013;5(20):5644-5656.

Woo H, Kim J, Han K, Lee J, Hwang I, Lee J, et al. Simultaneous analysis of 17 diuretics in dietary supplements by HPLC and LC-MS/MS. Food Addit Contam A. 2013;30(2):209-217.

Downloads

Published

2022-11-23

Issue

Section

Original Article

How to Cite

Smart Spectrophotometric Methods for Concurrent Determination of Furosemide and Spironolactone Mixture in Their Pharmaceutical Dosage Forms. (2022). Brazilian Journal of Pharmaceutical Sciences, 58. https://doi.org/10.1590/s2175-97902022e19487